Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.79 |
| ▸ | USP2 | O75604 | 4/20 | 0.79 |
| ▸ | LMNA | P02545 | 3/20 | 0.79 |
| ▸ | GAA | P10253 | 2/20 | 0.79 |
| ▸ | TSHR | P16473 | 2/20 | 0.79 |
| ▸ | PKM | P14618 | 1/20 | 0.79 |
| ▸ | CASP1 | P29466 | 1/20 | 0.79 |
| ▸ | CASP7 | P55210 | 1/20 | 0.79 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.79 |
| ▸ | GALR3 | O60755 | 1/20 | 0.74 |
| ▸ | TNF | P01375 | 1/20 | 0.74 |
| ▸ | RAB9A | P51151 | 1/20 | 0.74 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.74 |
| ▸ | ESR1 | P03372 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13091002 | 0.88 | ALDH1A1 (0.85) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL13943623 | 0.87 | SMN1; SMN2 (0.84) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL13091007 | 0.82 | HPGD (0.79) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL13091043 | 0.81 | HPGD (0.68) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL13091010 | 0.79 | ALDH1A1 (0.73) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL4254375 | 0.76 | ALDH1A1 (0.72) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL4256455 | 0.75 | GAA (0.72) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL13942923 | 0.75 | GAA (0.66) | HTTSMN1; SMN2ALDH1A1USP2LMNA | |
| SCHEMBL6517336 | 0.74 | MEN1 (0.70) | HTTSMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL17242569 | 0.74 | MEN1 (0.58) | HTTSMN1; SMN2ALDH1A1USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. | 2010-10-21 | — | — | US | disclosed |
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. | 2010-10-21 | — | — | US | disclosed |
| WO-2009023558-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. (US) | 2009-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | BAX, BCL2, BAD | HTT 1354/4885SMN1; SMN2 1154/4885ALDH1A1 3966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.